Wednesday, July 8, 2026

pharma · Acne Vulgaris · Plasmodium Falciparum Malaria · ATXI

AVENUE THERAPEUTICS

Avenue Therapeutics is a pharma organization headquartered in Bay Harbor Islands, USA. It trades on NYSE under ticker ATXI. Primary therapeutic focus areas include Acne Vulgaris, Plasmodium Falciparum Malaria, Neural Inh

Bay Harbor Islands, USA HQ
10 Employees
Public company Type
ATXI · NYSE Ticker
Company details
Status
Public
HQ
Bay Harbor Islands, USA
Employees
10
Programs
4
Drugs
8
Patents
1
Clinical program

Tramadol

Phase 3 · small molecule · Pain Management

Tramadol for Pain Management is a Phase 3 program (small_molecule) at AVENUE THERAPEUTICS, INC. with 3 ClinicalTrials.gov record(s).

← All AVENUE THERAPEUTICS, INC. projects Phase 3 small molecule active

Internal code AVE-901-102

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
AVENUE THERAPEUTICS, INC.
Phase
Phase 3
Modality
small_molecule
Indication
Pain Management
Status
active
Trials
3